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A BST R AC T   
 
Aim:  Couple of pneumonia cases were reported in a short period in Wuhan, China. The cases were revealed 
to be associated with a different coronavirus type was named SARS-CoV-2 and the disease was identified as 
Covid-19.  It is known that the disease occurs in all age groups. We aimed to evaluate the differences in clinical 
and laboratory features between adult and pediatric patients. 
Method: The study is a retrospective cross-sectional study and consists of 206 patients with a definitive 
diagnosis of Covid-19 confirmed by a positive real-time reverse-transcriptase polymerase chain reaction (RT-
PCR) testing for SARS-CoV-2. They hospitalized in health institutions connected to City Health 
Administrative of Bolu, Turkey between 11.03.2020 and 19.04.2020. The number of the pediatric patients (0-
17 age group) was 106, that of the adult patients (18 and above age group) was 100. Data concerning the 
patients consisted of age, symptoms, laboratory parameters such as hemogram, biochemistry, coagulation. 
Results: The mean values of platelet (PLT), platocrit (PCT), percentage of monocytes (MONO %) and MONO 
in the “0-17” age group were found to be significantly higher than the mean values in the “18 and above” age 
group. The hemoglobin (HGB) mean value of the “0-17” age group was significantly lower than that of the 
“18 and above” age group. The mean C - reactive protein (CRP) value of the “0-17” age group (4.55; min: 
1.20 – max: 11.80) was significantly lower than that of the “18 and above” age group (5.35; min 1.25- max: 
19.77) with no statistically significance. In pediatric group, the most common symptoms were other symptoms 
like diarrhea, vomiting and joint pain whereas the adult patients had fever and cough often with statistically 
significant. 
Conclusion: Clinical findings and laboratory abnormalities in Covid-19 are less common in children. 
Although it seems that Covid-19 is less symptomatic in children, they are also affected by the disease. 
Performing RT-PCR test based on the contact history of the children may help to minimize morbidity with an 
early diagnosis. Multicenter studies with more numbers of patients should be performed. 
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Introduction 
In December 2019, a couple of pneumonia 
cases were reported in a short period in Wuhan, 
China [1]. The cases were revealed to be 
associated with a different coronavirus type 
was named SARS-CoV-2 and the disease it 
caused was identified as Covid-19 [2]. While 
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other types of coronavirus such as SARS-CoV 
and MERS-CoV do not lead to severe diseases, 
SARS-CoV-2 have caused millions of deaths 
[3,4].  
It is known that Covid-19 occurs not only in 
adults but also in children [5]. However, 
children represent a very small proportion of 
cases and prior studies have shown that the 
mortality rate is much lower in them [6,7]. 
Moreover, it has been determined that the 
clinical picture in children is considerably 
milder than in adults [8]. The disease is 
diagnosed mostly with fever, cough, sneezing, 
sore throat, myalgia, pharyngeal erythema and 
runny nose. However, symptoms such as 
diarrhea, nausea, vomiting and malaise can also 
be seen [9]. Compared to adults, frequent 
laboratory abnormalities such as elevated CRP 
and procalcitonin levels and lymphopenia were 
found to be quite low in children diagnosed 
with Covid-19 [10]. In this study, we aimed to 
evaluate the differences in clinical and 
laboratory features between adult and pediatric 
patients to diagnose more effectively. 
 
Materials and methods 
The study is a retrospective cross-sectional 
study and consists of 206 patients with a 
definitive diagnosis of Covid-19 confirmed by 
a positive RT-PCR test after hospitalized in 
health institutions connected to City Health 
Administrative of Bolu, Turkey between 
11.03.2020 and 19.04.2020. Ethical approval of 
the study was obtained from Bolu Abant İzzet 
Baysal University Clinical Research Ethics 
Committee (Date: 12.05.2020, Number: 
2020/92). Data was obtained by scanning the 
patients from the Public Health Management 
System of City Health Administrative and 
Hospital Information Management System. 
Information about the patients consisted of age, 
symptoms, results of laboratory parameters 
such as white  blood  cell  count (WBC), 
hemoglobin (HGB),   hematocrit (Htc), 
lymphocyte count (LYM), platelet count (PLT), 
red blood cell (RBC), basophil (BASO), 
platocrit (PCT), neutrophil (NEU),monocyte 
(MONO), D-DIMER, C-Reactive protein 
(CRP) and lactate dehydrogenase (LDH). 
Clinical findings categorized as fever, cough 
and other symptoms like diarrhea, vomiting, 
anosmia, headache, joint pain and sore throat. 
Patients who didn’t apply during the mentioned 
dates were not included the study. Also 
pregnant women and patients with 
immunosuppressions, diabetes mellitus, 
chronic lung and kidney diseases, and 
hypertension were excluded. 
Statistical analyses 
For all statistical analyses, the 20.0 version of 
SPSS  (Statistical  Package  for  the  Social 
Sciences)  for  Windows,  (Chicago,  Illinois, 
USA)  was  used.  The numerical data were 
expressed as mean ± standard deviation. The 
difference between the study and the control 
groups was evaluated by Student t-test for data 
which were normally distributed. For the data 
which were not normally distributed Mann-
Whitney’s   U-test   was   used.  Chi-Square test 
was used in the analysis of categorical data.  
The correlation between EFT and MS was 
evaluated using Spearman’s correlation 




There were 206 patients in the study; 106 
patients between 0-17 years, 100 patients aged 
18 and above. The mean age was 13.52 (min: 1-
max: 17) in the “0-17” age group and 45.43 
(min: 18-max: 85) in the “18 and above” age 
group (p=0,000). 
The mean values of PLT, PCT, MONO% and 
MONO in the “0-17” age group were found to 
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be significantly higher than the mean values in 
the “18 and above” age group (p<0.05). The 
HGB mean value of the “0-17” age group was 
significantly lower than that of the “18 and 
above” age group (p<0.05) (Table 1).The mean 
CRP value of the “0-17” age group (4.55; min: 
1.20 – max: 11.80) was significantly lower than 
that of the “18 and above” age group (5.35; min 
1.25- max: 19.77) with no statistically 
































The percentages of the clinical findings were 
calculated for both age groups. In the ‘’0- 17’’ 
age group, the most common symptoms were 
other symptoms (54.8%) like diarrhea, 
vomiting, anosmia, sore throat and joint pain. 
(p=1.153)  The presence of fever (69%) and 
cough (69.9%) symptoms was significantly 



































Table 1. Laboratory results of age groups. 
 











WBC 5.83 (4.77-7.39) 5.50 (4.50-6.59) 5.76 (4.57-7.03) 0.062 
LYM 1.49 (1.01-2.00) 1.45 (1.15-1.93) 1.45 (1.1-1.96) 0.931 
HGB 13.50 (13.00-14.40) 14.25 (12.80-15.40) 13.70 (13-14.90) 0.024* 
BASO 0.02 (0.01-0.03) 0.034 (0-0.06) 0.03 (0.01-0.05) 0.390 
PLT 253.5 (216-293) 207.5 (172.5-247.0) 228.5 (196-273) 0.000* 
PCT 0.25 (0.22-0.29) 0.17 (0.14-0.21) 0.21 (0.17-0.26) 0.000* 
NEU 3.44 (2.40-5.00) 3.46 (2.41-4.60) 3.44 (2.4-4.76) 0.514 
D-DİMER 0.29 (0.21-0.58) 0.37 (0.22-0.59) 0.32 (0.21-0.58) 0.566 
LDH 234 (207-283) 222.5 (185-273.5) 230 (196-276) 0.073 
CRP 4.55 (1.20-11.80) 5.35 (1.25-19.77) 4.84 (1.2-14.7) 0.461 
𝑿 ± 𝒔𝒔*** 
Age 13.52±3.15 45.43±17.26 29.01±20.11 0.000* 
RBC 4.88±0.45 4.86±0.55 4.87±0.49 0.728 
LYM% 27.09±13.41 28.47±10.98 27.76±12.28 0.419 
MONO% 11.31±3.85 8.75±3.50 10.07±3.89 0.000* 
NEU% 59.98±14.56 61.39±12.02 60.66±13.37 0.447 
MONO 0.70±0.28 0.50±0.25 0.61±0.28 0.000* 
*a value of p<0.05 was taken statistically significant  
** Mann-Whitney U test               ***Independent Sample t test 
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In this study, we aimed to reveal the differences 
in clinical and laboratory features between adult 
and pediatric patients and tried to emphasize 
that children are also at risk for Covid-19 as 
different manifestations. 
It was observed that only 1.7% of the cases 



































until April 2020 were children. Despite the low 
incidence compared to adult patients, SARS-
CoV-2 is also seen in children and has been 
shown to be associated with milder clinical 
symptoms [11-13]. Of 206 patients in our study, 
106 (%51.5) were children, and the proportion 
was found to be quite higher according to USA 
data. We attributed this to the fact that children 
  Table 2. Chi-Square analysis of clinical findings according to age groups. 
Parameters 
“0-17” age group 
(n:106; %51.5) 








        
48 (%39.3) 74 (%69.0) 122 (%59.2) 
0.000* 
 










93 (%45.1) 0.000* 
 
34.129 












   115 (%55.8) 




a value of p<0.05 was taken statistically significant * Chi-Square test 
 
 
Figure 1. Relationship between age groups and fever. 
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were scanned and caught at the stage without 
symptoms. While none of pediatric patients 
needed intensive care, 3 of the adult patients 
were followed up in intensive care unit. Among 
100 adult patients 1 (1%) death occurred, but no 
death was seen in children. 
A study in China revealed that children had 
mild clinical symptoms and less need for 
intensive care compared to adults. In this study, 
the most common symptoms were cough 
(48.5%), pharyngeal erythema (46.2%) and 
fever (41.5%). It was reported that only 3 of 171 
patients needed intensive care and all of them 
had underlying diseases.[14] In our study, fever 
(39.3%), cough (29.0%) and other symptoms 
(54.8%) like diarrhea, vomiting, anosmia , joint 
pain and sore throat were recorded in children 
(Figure 1) On the other hand, major symptoms 
of adults were fever (69%) and cough (69.9%) 
while other symptoms (47.3%) noticed lower 
than children (Figure 2) In a Chinese study, 8 of 
10 pediatric patients had fever and 6 of them 
had cough confirming most common symptoms 
in children were similar to those in adults [15]. 
In a study performed by Yang et al. [16] with 
134 pediatric patients, the fever was found to be 
the most common symptom with 76.1%. 
In a study conducted by Chen et al. [17] with 
505 patients of whom 12 were children, it has 
been shown that lymphopenia seen in only 2 
patients was less common than adults. In our 
study, lymphopenia was similar in children as 
adults (mean LYM value in children: 1.49 – 
mean LYM value in adults 1.45). (Table 1) 
Moreover, it has been shown that the mean 
LYM value was lower in adults compared to 
pediatric patients. Xia et al. [18] researched 
that; 70% of pediatric patients had normal 
WBC count, 20% had leukopenia and 10% had 
leukocytosis. Additionally, lymphopenia 
(35%), elevated alanine aminotransferase 
(ALT) (25%), elevated CRP (45%) and 
elevated procalcitonin (80%) were the other 
laboratory abnormalities. In our pediatric 
patients; WBC, RBC, MONO, PLT, PCT and 
LDH were higher than adults whereas Hb, 
BASO, NEU, D DIMER and CRP were lower 
than adults. Among these findings, while the 
increase of PLT, PCT, MONO% and MONO 
and the decrease of Hb in the “0-17” age group 
were statistically significant. (p<0.05) (Table 
1). 
There may some explanations for the reasons 
between the differences in clinical features 
between adults and children. One of the study 
has been suggested that the virus in children is 
the second, third and sometimes fourth 
generation because of the transmission of the 
disease from adults, and compared to the first 
generation one it is more difficult for the virus 
to replicate, mutate and survive before it is 
recognized by the immune system [19]. 
Furthermore, it has been argued that natural 
immunity in children is more ready against such 
pathogens and immune system functions 
decrease with aging [19,20].  Considering that 
there is a curfew for people under 20 years of 
age since the beginning of the outbreak in 
Turkey, it can be concluded that children get the 
disease from adult members of the family. In 
addition to this, the children had a history of 
indirect contact and the disease in children was 
less symptomatic, the above-mentioned 
opinions seem to be reasonable. 
 
Conclusion 
Clinical findings and laboratory abnormalities 
in Covid-19 are less common in children. 
Although it seems that Covid-19 is less 
symptomatic in children, they are also affected 
by the disease. Performing RT-PCR test based 
on the contact history of the children may help 
to minimize morbidity with an early diagnosis. 
Multicenter studies with more numbers of 
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patients should be performed for more accurate 
outcomes. 
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